These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1067 related items for PubMed ID: 19702031

  • 1. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
    Kircik L.
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
    [Abstract] [Full Text] [Related]

  • 2. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Lebwohl M, Menter A, Weiss J, Clark SD, Flores J, Powers J, Balin AK, Kempers S, Glinert RJ, Fleming T, Liu Y, Graeber M, Pariser DM.
    J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
    [Abstract] [Full Text] [Related]

  • 3. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
    Abramovits W.
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
    [Abstract] [Full Text] [Related]

  • 4. Calcitriol ointment: optimizing psoriasis therapy.
    Gold LF.
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s23-7. PubMed ID: 19702033
    [Abstract] [Full Text] [Related]

  • 5. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P, Andres P.
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [Abstract] [Full Text] [Related]

  • 6. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M, Mrowietz U, Koenig M, Simon JC.
    Eur J Dermatol; 2003 Apr; 13(3):261-5. PubMed ID: 12804986
    [Abstract] [Full Text] [Related]

  • 7. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis.
    Langner A, Ashton P, Van De Kerkhof PC, Verjans H.
    Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
    Liao YH, Chiu HC, Tseng YS, Tsai TF.
    Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 15. Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study.
    Kragballe K, Fogh K, Søgaard H.
    Acta Derm Venereol; 1991 Jun; 71(6):475-8. PubMed ID: 1685828
    [Abstract] [Full Text] [Related]

  • 16. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity.
    Queille-Roussel C, Duteil L, Parneix-Spake A, Arsonnaud S, Rizova E.
    Eur J Dermatol; 2001 Jun; 11(3):219-24. PubMed ID: 11358728
    [Abstract] [Full Text] [Related]

  • 17. Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study.
    Durakovic C, Ray S, Holick MF.
    Br J Dermatol; 2004 Jul; 151(1):190-5. PubMed ID: 15270890
    [Abstract] [Full Text] [Related]

  • 18. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, Oranje AP, de Rie MA, de Waard-van der Spek FB, Hol CW, van de Kerkhof PC.
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [Abstract] [Full Text] [Related]

  • 19. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G, Aldebani S, Elzorghany A, Benghazil M, Alhaddar J.
    Int J Clin Pharmacol Res; 2003 Feb; 23(2-3):47-51. PubMed ID: 15018018
    [Abstract] [Full Text] [Related]

  • 20. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903).
    Kragballe K.
    Arch Dermatol; 1989 Dec; 125(12):1647-52. PubMed ID: 2531570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.